The landscape of dementia prognosis has advanced drastically with the appearance of sophisticated biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent assessments which can detect Alzheimer's pathology many years just before signs arise. When these technological innovations represent outstanding progress in comprehension n